Genelux Corp IPOs Tomorrow, Here's What You Need To Know

Genelux Corp GNLX IPO will take place January, 26 on the NASDAQ exchange under the ticker GNLX.

The company is offering shares at an expected price between $6.00 and $7.00 per share with an insider lock-up period of 180 days ending on July 25, 2023.

See also: Benzinga IPO Calendar

About Genelux Corp

Genelux is a clinical-stage biopharmaceutical company focused on developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.